Human Cord Blood Platelet-Rich Plasma (hCB-PRP) was obtained from plasma isolated from umbilical cord blood (CB) collected with citrate phosphate dextrose adenine (CPDA-1) as anticoagulant. Cord blood was obtained using Institutional Review Board approved consent form. hCB-PRP was processed and cryopreserved within 48 hours following the collection of cord blood to achieve maximum quality and viability.
Frozen, no cryopreservation medium
Plasma, Single Donor
Citrate phosphate dextrose adenine (CPDA-1)
Chagas (anti-T. cruzi), HBV, HCV nucleic acid testing, Hepatitis B core antibody (anti-HepB), Hepatitis C antibody (anti-HCV), HIV 1/2, HIV-1/2 (anti-HIV-1/2), HTLV I/II antibody (anti-HTLV I/II), Maternal blood sample of donor tested and reported negative for hepatitis B surface antigen (HBsAg), Syphilis screening, WNV nucleic acid testing
Stability and Storage
Product is stable at -80℃ for 12 months from the date of receipt. Thawed samples should be used immediately.
Handling / Directions for use
- Thaw in a 37°C water bath or plasma can be thawed at 2 – 8°C overnight.
- Wipe the outside of the vial with 70% ethanol or isopropanol.
- Plasma is ready for use in downstream applications.
This product contains human biological material and MUST be treated as potentially infectious or contaminated materials and be handled in biological safety level 2. Even if maternal blood screening reports are negative, it cannot completely guarantee that the product is virus-free.
Mononuclear Therapeutics cannot guarantee the biological function or any other properties associated with performance of plasma in a researcher’s individual assay or culture system.
FOR IN VITRO RESEARCH USE ONLY. NOT APPROVED FOR DIAGNOSTIC, THERAPEUTIC, OR CLINICAL APPLICATIONS. NOT APPROVED FOR HUMAN OR VETERINARY USE IN VIVO.